
|Articles|May 30, 2019
Reducing Influenza Duration, Related Complications and Healthcare Costs with Novel Antivirals
https://www.pharmacytimes.org/on-demand/ajmc-payer-forum-reducing-influenza-duration-related-complications-and-healthcare-costs-with-novel-antivirals
Advertisement
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
ATTR-CM Incidence, Prevalence Rose Sharply in the US
3
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
4
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
5




